Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Naproxen
Atnahs Pharma Netherlands B.V.
M01AE; M01AE02
Naproxen
500 milligram(s)
Gastro-resistant tablet
Propionic acid derivatives; naproxen
Marketed
1990-07-04
_1 _ _ _ PACKAGE LEAFLET: INFORMATION FOR THE PATIENT NAPROSYN ® EC 250MG GASTRO-RESISTANT TABLET NAPROSYN ® EC 500MG GASTRO-RESISTANT TABLET Naproxen PLEASE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. IN THIS LEAFLET: 1. What Naprosyn EC is and what it is used for 2. What you need to know before you take Naprosyn EC 3. How to take Naprosyn EC 4. Possible side effects 5. How to store Naprosyn EC 6. Contents of the pack and other information Naprosyn EC contains a medicine called naproxen. This is a ‘Non Steroidal Anti Inflammatory Drug’ or NSAID. Naprosyn EC can lessen pain, swelling, redness and heat (inflammation) and is used to: relieve problems with your muscles, joints and tendons, e.g. strains, back pain, ankylosing spondylitis (pain and stiffness in the neck and back), gout, rheumatoid arthritis or osteoarthrosis. relieve period pain in women. Naprosyn EC tablets are used to treat adults and adolescents (16 years and above). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NAPROSYN EC DO NOT TAKE NAPROSYN EC IF YOU ARE ALLERGIC (HYPERSENSITIVE) TO: Naproxen, naproxen sodium or any of the other ingredients of Naprosyn EC (listed in section 6). Aspirin, other NSAIDs or any other pain relief medicines (such as ibuprofen or diclofenac). DO NOT TAKE NAPROSYN EC IF: you have now or have ever had any problems with your stomach or gut (intestine) e.g. an ulcer or bleeding. you have previously experienced bleeding or perforation in your stomach while taking NSAIDs. you have SEVERE problems with your kidneys Read the complete document
Health Products Regulatory Authority 07 May 2021 CRN00C851 Page 1 of 10 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Naprosyn EC 500mg Gastro-resistant Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 500mg Naproxen. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Gastro-resistant tablets. Capsule-shaped, white film-coated tablet marked ‘NPR EC 500’ in black ink on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Naprosyn EC is indicated in adults and adolescents (16 years and above) for the treatment of rheumatoid arthritis, osteoarthrosis (degenerative arthritis), ankylosing spondylitis, acute gout, acute musculo-skeletal disorders (such as sprains and strains, direct trauma, lumbosacral pain, cervical spondylitis, tenosynovitis and fibrositis) and dysmenorrhoea. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY For oral administration Naprosyn EC tablets should be swallowed whole and not broken or crushed. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). _ADULTS:_ _RHEUMATOID ARTHRITIS, OSTEOARTHRITIS AND ANKYLOSING SPONDYLITIS:_ The usual dose is 500mg to 1g daily taken in two doses at 12-hour intervals. Where 1g per day is needed one 500mg tablet twice daily or two 500mg tablets in a single administration (morning or evening) is recommended. _ACUTE GOUT:_ The recommended dosage is 750mg initially, then 250mg every eight hours until the attack has passed. _ACUTE MUSCULO-SKELETAL DISORDERS AND DYSMENORRHOEA:_ The recommended dose is 500mg initially followed by 250mg at 6 - 8 hour intervals as needed, with a maximum daily dose after the first day of 1250mg. _OLDER PEOPLE:_ Studies indicate that although total plasma concentration of naproxen is unchanged, the unbound plasma fraction of naproxen is increased in older people. The implication of this finding for Naprosyn EC dosing is unknown. As with other drugs used in older people it Read the complete document